GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...
Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are ...
Dr. John Sosa, a double board-certified expert in family and lifestyle medicine and the Chief Medical Officer for Drip Health ...
A new Northbrook pharma will work to bring its obesity treatment to market that it says holds advantages over Ozempic and its ...
In a practice-changing guideline reversal, medical societies advised on Tuesday that most patients do not need to stop taking ...
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...
As open enrollment kicks off, employees may find an unpleasant surprise in their 2025 health insurance premiums. Increased adoption of GLP-1 drugs, rising catastrophic claims and other cost pressures ...
There's a new player in the running game, and it's not the latest carbon-plated shoe or fancy GPS watch. GLP-1 medications ...